Cargando…
Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy
BACKGROUND: Neoadjuvant concurrent chemoradiotherapy (nCCRT) is a standard treatment for locally advanced rectal cancer (LARC). The gut microbiome may be reshaped by radiotherapy through its effects on microbial composition, mucosal immunity, and the systemic immune system. We sought to clarify dyna...
Autores principales: | Sun, Yi, Zhang, Xiang, Jin, Chuandi, Yue, Kaile, Sheng, Dashuang, Zhang, Tao, Dou, Xue, Liu, Jing, Jing, Hongbiao, Zhang, Lei, Yue, Jinbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041716/ https://www.ncbi.nlm.nih.gov/pubmed/36967379 http://dx.doi.org/10.1186/s12967-023-04054-1 |
Ejemplares similares
-
The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer
por: Sheng, Dashuang, et al.
Publicado: (2023) -
Bidirectional Mediation Effects between Intratumoral Microbiome and Host DNA Methylation Changes Contribute to Stomach Adenocarcinoma
por: Yue, Kaile, et al.
Publicado: (2023) -
Consolidation chemotherapy may improve pathological complete response for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a retrospective study
por: Cui, Jin, et al.
Publicado: (2020) -
Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer
por: Liu, Chao, et al.
Publicado: (2022) -
Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2005)